Andera life sciences

Andera life sciences funds the development of innovative medical solutions, which are based on strong scientific hypotheses, supported by robust preclinical or clinical data, and protected by strong intellectual property. They take an active role in our investments, backing talented entrepreneurs to take their innovations to major value inflexion points. 

They invest across Europe and US, companies size can vary from start-up/early-stage to growth/late-stage, and must be headquartered in Paris or Munich.
Their amounts invested per company ranges from €5m to €35m.

Andera Partners has raised a total of $3.3B across 8 funds, their latest being BioDiscovery 6 Fund. This fund was announced on Oct 10, 2022 and raised a total of €456M.

Areas of activity

They offer several investment strategies to support:

- Companies driving therapeutic and medical innovation in Europe and the United States: andera Life Sciences makes equity investments from €5m to €35m,

- Green innovative infrastructures in Europe and mainly in France: andera Infra makes equity investments from €5m to €30m

- European SMEs and mid-caps with annual revenues between €10m and €500m:
– andera Croissance: €3m to €10m in equity financing
– andera Expansion: €10m to €25m in equity financing
– andera MidCap: €25m to €100m in equity financing
– andera Acto: €5m to €100m in mezzanine financing

Portfolio: NG Travel, Fire1, SoniVie, Redslim.